Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Revenue (2023 - 2025)

Bioharvest Sciences has reported Revenue over the past 3 years, most recently at $9.1 million for Q4 2025.

  • For Q4 2025, Revenue rose 24.57% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $34.5 million, up 37.0%, while the annual FY2025 figure was $34.5 million, 37.0% up from the prior year.
  • Revenue was $9.1 million for Q4 2025 at Bioharvest Sciences, roughly flat from $9.1 million in the prior quarter.
  • Across five years, Revenue topped out at $9.1 million in Q3 2025 and bottomed at $2.8 million in Q2 2023.
  • The 3-year median for Revenue is $6.5 million (2024), against an average of $6.4 million.
  • Year-over-year, Revenue skyrocketed 119.16% in 2024 and then grew 24.57% in 2025.
  • Over 3 years, Revenue stood at $4.5 million in 2023, then surged by 61.02% to $7.3 million in 2024, then increased by 24.57% to $9.1 million in 2025.
  • The last three reported values for Revenue were $9.1 million (Q4 2025), $9.1 million (Q3 2025), and $8.5 million (Q2 2025) per Business Quant data.